{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:30:53Z","timestamp":1761183053462,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20HA2003"],"award-info":[{"award-number":["20HA2003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jiac.2021.12.004","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T17:31:37Z","timestamp":1639416697000},"page":"356-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The intended purpose and regional patterns of use of antibiotics for managing Clostridioides (Clostridium) difficile infections: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups data of Japan"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4874-0377","authenticated-orcid":false,"given":"Ryo","family":"Inose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6951-5676","authenticated-orcid":false,"given":"Yuichi","family":"Muraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Kamimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7072-2338","authenticated-orcid":false,"given":"Yoshiki","family":"Kusama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ishikane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.12.004_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/b\/9-13","article-title":"Recent advances in the treatment of Clostridioides difficile infection: the ever-changing guidelines","volume":"9","author":"Khurana","year":"2020","journal-title":"Fac Rev"},{"issue":"7","key":"10.1016\/j.jiac.2021.12.004_bib2","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jiac.2021.12.004_bib3","first-page":"1","article-title":"CDI clinical practice guideline development committee. The Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infections","volume":"68","year":"2020","journal-title":"Jpn J Chemotarapy"},{"issue":"4","key":"10.1016\/j.jiac.2021.12.004_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1248\/bpb.b19-01000","article-title":"The trend for antibiotic use for Clostridioides (Clostridium) difficile infection in Japan","volume":"43","author":"Ishii","year":"2020","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"10.1016\/j.jiac.2021.12.004_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s15010-017-1097-x","article-title":"The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011\u20132013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group","volume":"46","author":"Yamasaki","year":"2018","journal-title":"Infection"},{"issue":"7","key":"10.1016\/j.jiac.2021.12.004_bib6","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jiac.2021.02.009","article-title":"An alternative index for evaluating AMU and anti-methicillin-resistant Staphylococcus aureus agent use: a study based on the National Database of Health Insurance Claims and Specific Health Checkups data of Japan","volume":"27","author":"Mita","year":"2021","journal-title":"J Infect Chemother"},{"issue":"5","key":"10.1016\/j.jiac.2021.12.004_bib7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7883\/yoken.JJID.2018.417","article-title":"Regional variation of antimicrobial use in Japan from 2013\u20132016, as estimated by the sales data","volume":"72","author":"Kusama","year":"2019","journal-title":"Jpn J Infect Dis"},{"issue":"5","key":"10.1016\/j.jiac.2021.12.004_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"10.1016\/j.jiac.2021.12.004_bib10","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/JCM.00740-07","article-title":"Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005","volume":"45","author":"Kobayashi","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.jiac.2021.12.004_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4292\/wjgpt.v6.i4.183","article-title":"Antibiotic treatment for Helicobacter pylori: is the end coming?","volume":"6","author":"Kim","year":"2015","journal-title":"World J Gastrointest Pharmacol Ther"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21003408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21003408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:02:57Z","timestamp":1761159777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21003408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1341321X21003408"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.12.004","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The intended purpose and regional patterns of use of antibiotics for managing Clostridioides (Clostridium) difficile infections: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups data of Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}